Cupid, a consumer wellness company, saw its shares surge 178% in 2026, driven by growing orders and expansion plans. This follows a 584% surge in 2025. The stock's recent rally has enhanced its market cap to ₹25,000 crore, benefiting retail investors significantly.
Cupid, a consumer wellness company, saw its shares surge 178% in 2026, driven by growing orders and expansion plans. This follows a 584% surge in 2025. The stock's recent rally has enhanced its market cap to ₹25,000 crore, benefiting retail investors significantly.
<iframe src="https://hindustansphere.com/embed/cluster/0846e9cbcce83371c092d2d10885c083b11aab54" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Small-cap pharma stock rallies 178% in 2026, extends winning run into fifth year; key factors behind rally"></iframe>
